Search Results for agency_names:"Health and Human Services Department"

The National Institute on Minority Health and Health Disparities is holding a closed meeting on February 5, 2025, to review grant applications. This meeting will take place virtually from 10:00 a.m. to 6:00 p.m. and involves discussing confidential information that requires privacy. The event is part of efforts to strengthen research opportunities for NIH grants, specifically focusing on resource-limited institutions.

The Center for Scientific Review announced several closed meetings to evaluate grant applications for scientific research. These meetings are scheduled to take place virtually at the National Institutes of Health on specific dates in February 2025 and will be restricted to the public to protect confidential information and personal privacy. Various committees focusing on fields such as cardiovascular science, bioengineering, oncology, biobehavioral processes, social psychology, and endocrinology will hold these sessions. Scientific Review Officers are designated for each committee to manage the proceedings and can be contacted for further information.

The Food and Drug Administration (FDA) has released a new guidance document for the industry titled “Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act.” This document establishes the conditions for compounding certain drugs and explains the FDA’s current approach while developing a list of bulk drug substances permitted for use. This guidance replaces a previous version from 2017 and provides instructions on submitting comments to the FDA. The guidance clearly states it is not legally binding but shows the FDA's current thinking on this issue.

The National Cancer Institute, part of the National Institutes of Health, is considering giving Iovance Biotherapeutics, Inc. an exclusive patent license. This license would allow Iovance to develop and sell specific cancer treatment products using a patented method involving engineered cells that could improve anti-tumor action. Interested parties have until March 12, 2021, to submit comments or objections. This license could cover worldwide rights and mainly focuses on treating several types of cancers, excluding certain specific methods.

The National Center for Complementary and Integrative Health announced a closed meeting on February 21, 2025, to evaluate grant applications related to early-phase clinical trials of natural products. This meeting, set to take place virtually, is closed to the public to protect confidential information, including trade secrets and personal data. The meeting will be led by Scientific Review Officer Jessica M. McKlveen, Ph.D., and will follow guidelines from the Federal Advisory Committee Act.

The National Institute on Aging, part of the National Institutes of Health, has announced a closed meeting scheduled for February 13-14, 2025. This meeting will focus on reviewing and evaluating grant applications and will be held virtually. The reason for the meeting being closed to the public is to protect confidential information, including trade secrets and personal details about individuals. The meeting details were filed on December 31, 2024, with reference document number 2024-31444.

The Agency for Healthcare Research and Quality (AHRQ), under the Department of Health and Human Services, announced five upcoming subcommittee meetings that will handle the review and discussion of grant applications. These meetings will be closed to the public to protect confidential information. The meetings are scheduled virtually on specific dates in February 2025, focusing on topics like healthcare safety, outcomes research, system value, research training, and information technology. For more details, interested parties can contact Jenny Griffith at AHRQ.

The National Institutes of Health (NIH) has restructured its All of Us Research Program, moving it from the NIH Office of the Director to the Division of Program Coordination, Planning, and Strategic Initiatives. This reorganization was approved by the Secretary of Health and Human Services in December 2024. Additionally, they established a new program office focused on environmental health impacts on children. The changes aim to improve research efforts and enhance collaboration among different health initiatives.

The National Institute on Aging, a part of the National Institutes of Health, announced a closed meeting scheduled for April 22, 2025. This meeting will focus on reviewing and evaluating grant applications related to "Psychedelic-Assisted Therapy for Chronic Pain." The meeting will be held virtually, ensuring the protection of confidential and personal information. The notice emphasizes compliance with specific legal provisions to maintain privacy and confidentiality.

The Centers for Disease Control and Prevention (CDC), part of the U.S. Department of Health and Human Services, has announced a public meeting of the Advisory Committee on Immunization Practices (ACIP) scheduled for January 27, 2021. The meeting will discuss COVID-19 vaccines and other topics, and will be live-streamed online. The public is encouraged to submit written comments by January 27 and may request to deliver oral comments during the meeting. Due to the ongoing COVID-19 pandemic, less than the usual 15 days' notice is being given for this event.